查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1678691

精准基因组检测市场规模、份额、趋势分析报告：2025 年至 2030 年按产品/服务、应用、技术、地区和细分市场预测

Precision Genomic Testing Market Size, Share & Trends Analysis Report By Product & Service (Consumables, Equipment, Services), By Application (Oncology, Cardiovascular Diseases), By Technology, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10个工作天内

价格

精准基因组检测市场趋势

2024 年全球精准基因组检测市场价值预计为 154.9 亿美元，预计在基因组技术的进步和个人化医疗日益重视的推动下，2025 年至 2030 年的复合年增长率为 14.80%。

该市场包括一系列用于分析遗传资讯的诊断工具和技术，从而实现更准确的诊断、有针对性的治疗并改善患者的治疗效果。精准基因组检测的需求源自于更早发现疾病、制定有效治疗方案、更好地管理慢性病的需求。

以CRISPR-Cas9基因组编辑技术为驱动的精准基因组检测，随着技术不断创新研发投入不断加大，发展动能强劲。因此，未来几年市场将强劲扩张。例如，2024 年 3 月，高级基因组学合作组织 (TAGC) 向由墨尔本大学主导并与墨尔本生物医学处方公司各营业单位合作的四个创新计划提供了资金。这些计划还将获得 TAGC 世界一流基因组学中心的尖端 DNA 测序技术，该技术由墨尔本大学与全球生物技术公司 Illumina 合作实现，并得到了维多利亚州投资局的支持。

遗传疾病和慢性疾病的增加推动了对精准基因组检测的需求。根据世界卫生组织 (WHO) 统计，估计有 10,000 种单基因疾病是由单一基因突变引起的，每 1,000 人中约有 10 人受到影响。这意味着全世界有近7000万至8000万人患有这种疾病。囊肿纤维化、亨丁顿舞蹈症和各种癌症等疾病对患者的健康和生活品质有重大影响。早期准确的诊断对于有效的治疗和管理至关重要。精准基因组检测可以识别致病的基因突变，从而及时干预和製定个人化的治疗方案。随着此类疾病的发生率不断上升，对可靠、全面的基因组检测解决方案的需求将推动市场成长。

此外，学术机构、研究机构、医疗保健提供者和生物技术公司之间的合作正在加速市场扩张。这些伙伴关係透过促进知识交流、资源共用和技术进步来促进创新。与製药公司的策略合作将进一步将精准基因组检测融入药物开发和个人化医疗中。随着协作生态系统的发展，精准基因组检测产业预计将持续成长。

目录

第一章调查方法与范围

第 2 章执行摘要

3. 精准基因组检测市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 精准基因组检测市场分析工具
    • 产业分析 – 波特五力分析
    • PESTEL 分析
    • COVID-19影响分析
  • 基因组检测成本分析
  • 人工智慧在基因组检测的应用

第四章精准基因组检测市场：产品与服务、估计与趋势分析

  • 细分仪表板
  • 全球精准基因组检测市场产品与服务变化分析
  • 2018 年至 2030 年全球精准基因组检测市场规模及趋势分析（依产品及服务）
  • 耗材
    • 套件
    • 试剂
  • 装置
  • 服务

第五章 精准基因组检测市场：按应用分類的估计和趋势分析

  • 细分仪表板
  • 全球精准基因组检测市场应用变化分析
  • 2018 年至 2030 年全球精准基因体检测市场规模及趋势分析（依应用）
  • 肿瘤学
  • 心血管疾病
  • 神经系统疾病
  • 生殖健康
  • 罕见疾病
  • 其他的

第六章 精准基因组检测市场：依技术、估计与趋势分析

  • 细分仪表板
  • 全球精准基因组检测市场技术变革分析
  • 2018 年至 2030 年全球精准基因体检测市场规模及趋势分析（依技术分类）
  • 新一代定序
  • 聚合酵素链锁反应
  • 微阵列技术
  • 桑格定序
  • CRISPR/Cas 系统
  • 其他的

第七章精准基因组检测市场：依最终用途的估计与趋势分析

  • 细分仪表板
  • 全球精准基因组检测市场最终用途变异分析
  • 2018 年至 2030 年全球精准基因组检测市场规模及趋势分析（依最终用途）
  • 医院和诊所
  • 诊断实验室
  • 研究和学术机构
  • 其他的

第 8 章 精准基因组检测市场：按产品/服务、应用、技术、最终用途、地区进行的估计和趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 2018-2030 年市场规模及预测趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争格局

  • 公司分类
  • 战略地图
  • 2024 年企业市场分析
  • Competitive Scenario
  • 公司简介/上市公司
    • Danaher
    • Merck KGaA
    • Revvity, Inc.
    • Maravai LifeSciences
    • GenScript
    • QIAGEN
    • PacBio
    • Oxford Nanopore Technologies plc.
    • Illumina, Inc.
    • 10x Genomics, Inc.
Product Code: GVR-4-68040-352-1

Precision Genomic Testing Market Trends:

The global precision genomic testing market size was estimated at USD 15.49 billion in 2024 and is projected to grow at a CAGR of 14.80% from 2025 to 2030, due to advancements in genomic technologies and an increasing emphasis on personalized medicine. This market encompasses a range of diagnostic tools and techniques used to analyze genetic information, leading to more accurate diagnoses, targeted therapies, and improved patient outcomes. The demand for precision genomic testing is driven by the need for early disease detection, effective treatment planning, and better management of chronic conditions.

Precision genomic testing, driven by CRISPR-Cas9 genome editing technology, is gaining momentum with continuous innovations and increasing investment in research and development. As a result, the market is poised for robust expansion in the coming years. For instance, in March 2024, The Advanced Genomics Collaboration (TAGC) awarded funding to four Innovation Projects led by the University of Melbourne in partnership with entities across the Melbourne Biomedical Precinct. These projects will also benefit from access to cutting-edge DNA sequencing technology at TAGC's world-class genomics hub, made possible through a collaboration between the University and global biotech firm Illumina, with backing from Invest Victoria.

The rising prevalence of genetic disorders and chronic diseases is driving the demand for precision genomic testing. An estimated 10,000 single-gene diseases result from mutations in a single gene, affecting approximately 10 out of every 1,000 people, according to the World Health Organization. This translates to nearly 70-80 million individuals worldwide living with such conditions. Disorders like cystic fibrosis, Huntington's disease, and various cancers significantly impact on patient health and quality of life. Early and accurate diagnosis is essential for effective treatment and management. Precision genomic testing enables the identification of disease-causing genetic mutations, allowing for timely interventions and personalized treatment plans. As the incidence of these conditions continues to rise, the need for reliable and comprehensive genomic testing solutions will drive market growth.

Additionally, collaborations among academic institutions, research organizations, healthcare providers, and biotechnology companies are accelerating market expansion. These partnerships foster innovation by facilitating knowledge exchange, resource sharing, and technological advancements. Strategic alliances with pharmaceutical firms further integrate precision genomic testing into drug development and personalized medicine. As the collaborative ecosystem grows, the precision genomic testing industry is expected to see sustained growth.

Global Precision Genomic Testing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global precision genomic testing market report based on product & service, application, technology, end use, and region:

  • Product & Service Outlook (Revenue, USD Billion, 2018 - 2030)
  • Consumables
    • Kits
    • Reagents
  • Equipment
  • Services
  • Application Outlook (Revenue, USD Billion, 2018 - 2030)
  • Oncology
  • Cardiovascular Diseases
  • Neurological Disorders
  • Reproductive Health
  • Rare Diseases
  • Others
  • Technology Outlook (Revenue, USD Billion, 2018 - 2030)
  • Next-Generation Sequencing
  • Polymerase Chain Reaction
  • Microarray Technology
  • Sanger Sequencing
  • CRISPR/Cas Systems
  • Others
  • End Use Outlook (Revenue, USD Billion, 2018 - 2030)
  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Research & Academic Institutes
  • Others
  • Regional Outlook (Revenue, USD Billion, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product & Service Segment
    • 1.2.2. Application Segment
    • 1.2.3. Technology Segment
    • 1.2.4. End Use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Precision Genomic Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising demand for personalized medicine
      • 3.2.1.2. Advancements in genomic testing technology
      • 3.2.1.3. Increasing government funding & growing focus on genomic studies
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Ethical and safety concerns related to precision genomic testing technologies
  • 3.3. Precision Genomic Testing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis
  • 3.4. Genomic Testing Cost Analysis
  • 3.5. AI Applications in Genomic Testing

Chapter 4. Precision Genomic Testing Market: Product & Service Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Precision Genomic Testing Market Product & Service Movement Analysis
  • 4.3. Global Precision Genomic Testing Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Billion)
  • 4.4. Consumables
    • 4.4.1. Consumables market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.4.2. Kits
      • 4.4.2.1. Kits market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.4.3. Reagents
      • 4.4.3.1. Reagents market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.5. Equipment
    • 4.5.1. Equipment market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.6. Services
    • 4.6.1. Services market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 5. Precision Genomic Testing Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Precision Genomic Testing Market Application Movement Analysis
  • 5.3. Global Precision Genomic Testing Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Billion)
  • 5.4. Oncology
    • 5.4.1. Oncology market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 5.5. Cardiovascular Diseases
    • 5.5.1. Cardiovascular diseases market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 5.6. Neurological Disorders
    • 5.6.1. Neurological disorders market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 5.7. Reproductive Health
    • 5.7.1. Reproductive health market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 5.8. Rare Diseases
    • 5.8.1. Rare diseases market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 5.9. Others
    • 5.9.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 6. Precision Genomic Testing Market: Technology Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Precision Genomic Testing Market Technology Movement Analysis
  • 6.3. Global Precision Genomic Testing Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Billion)
  • 6.4. Next-Generation Sequencing
    • 6.4.1. Next-generation sequencing market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 6.5. Polymerase Chain Reaction
    • 6.5.1. Polymerase chain reaction market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 6.6. Microarray Technology
    • 6.6.1. Microarray technology market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 6.7. Sanger Sequencing
    • 6.7.1. Sanger sequencing market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 6.8. CRISPR/Cas Systems
    • 6.8.1. CRISPR/Cas systems market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 6.9. Others
    • 6.9.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 7. Precision Genomic Testing Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Precision Genomic Testing Market End Use Movement Analysis
  • 7.3. Global Precision Genomic Testing Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Billion)
  • 7.4. Hospitals and Clinics
    • 7.4.1. Hospitals and clinics market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 7.5. Diagnostic Laboratories
    • 7.5.1. Diagnostic laboratories market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 7.6. Research & Academic Institutes
    • 7.6.1. Research & academic institutes market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 7.7. Others
    • 7.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 8. Precision Genomic Testing Market: Regional Estimates & Trend Analysis by Product & Service, Application, Technology, and End Use

  • 8.1. Regional Market Share Analysis, 2024 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 8.4. North America
    • 8.4.1. North America market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 8.4.2. U.S.
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Competitive scenario
      • 8.4.2.3. Regulatory framework
      • 8.4.2.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 8.4.3. Canada
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Competitive scenario
      • 8.4.3.3. Regulatory framework
      • 8.4.3.4. Canada market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 8.4.4. Mexico
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Competitive scenario
      • 8.4.4.3. Regulatory framework
      • 8.4.4.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.5. Europe
    • 8.5.1. Europe market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 8.5.2. UK
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Competitive scenario
      • 8.5.2.3. Regulatory framework
      • 8.5.2.4. UK market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 8.5.3. Germany
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Competitive scenario
      • 8.5.3.3. Regulatory framework
      • 8.5.3.4. Germany market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 8.5.4. France
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Competitive scenario
      • 8.5.4.3. Regulatory framework
      • 8.5.4.4. France market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 8.5.5. Italy
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Competitive scenario
      • 8.5.5.3. Regulatory framework
      • 8.5.5.4. Italy market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 8.5.6. Spain
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Competitive scenario
      • 8.5.6.3. Regulatory framework
      • 8.5.6.4. Spain market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 8.5.7. Denmark
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Competitive scenario
      • 8.5.7.3. Denmark market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 8.5.8. Sweden
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Competitive scenario
      • 8.5.8.3. Regulatory framework
      • 8.5.8.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 8.5.9. Norway
      • 8.5.9.1. Key country dynamics
      • 8.5.9.2. Competitive scenario
      • 8.5.9.3. Regulatory framework
      • 8.5.9.4. Norway market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 8.6.2. Japan
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Competitive scenario
      • 8.6.2.3. Regulatory framework
      • 8.6.2.4. Japan market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 8.6.3. China
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Competitive scenario
      • 8.6.3.3. Regulatory framework
      • 8.6.3.4. China market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 8.6.4. India
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Competitive scenario
      • 8.6.4.3. Regulatory framework
      • 8.6.4.4. India market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 8.6.5. Australia
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Competitive scenario
      • 8.6.5.3. Regulatory framework
      • 8.6.5.4. Australia market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 8.6.6. South Korea
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Competitive scenario
      • 8.6.6.3. Regulatory framework
      • 8.6.6.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 8.6.7. Thailand
      • 8.6.7.1. Key country dynamics
      • 8.6.7.2. Competitive scenario
      • 8.6.7.3. Regulatory framework
      • 8.6.7.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.7. Latin America
    • 8.7.1. Latin America market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 8.7.2. Brazil
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Competitive scenario
      • 8.7.2.3. Regulatory framework
      • 8.7.2.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 8.7.3. Argentina
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Competitive scenario
      • 8.7.3.3. Regulatory framework
      • 8.7.3.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.8. MEA
    • 8.8.1. MEA market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 8.8.2. South Africa
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Competitive scenario
      • 8.8.2.3. Regulatory framework
      • 8.8.2.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Competitive scenario
      • 8.8.3.3. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 8.8.4. UAE
      • 8.8.4.1. Key country dynamics
      • 8.8.4.2. Competitive scenario
      • 8.8.4.3. Regulatory framework
      • 8.8.4.4. UAE market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key country dynamics
      • 8.8.5.2. Competitive scenario
      • 8.8.5.3. Regulatory framework
      • 8.8.5.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2024
  • 9.4. Competitive Scenario
  • 9.5. Company Profiles/Listing
    • 9.5.1. Danaher
      • 9.5.1.1. Company overview
      • 9.5.1.2. Financial performance
      • 9.5.1.3. Product & service benchmarking
      • 9.5.1.4. Strategic initiatives
    • 9.5.2. Merck KGaA
      • 9.5.2.1. Company overview
      • 9.5.2.2. Financial performance
      • 9.5.2.3. Product & service benchmarking
      • 9.5.2.4. Strategic initiatives
    • 9.5.3. Revvity, Inc.
      • 9.5.3.1. Company overview
      • 9.5.3.2. Financial performance
      • 9.5.3.3. Product & service benchmarking
      • 9.5.3.4. Strategic initiatives
    • 9.5.4. Maravai LifeSciences
      • 9.5.4.1. Company overview
      • 9.5.4.2. Financial performance
      • 9.5.4.3. Product & service benchmarking
      • 9.5.4.4. Strategic initiatives
    • 9.5.5. GenScript
      • 9.5.5.1. Company overview
      • 9.5.5.2. Financial performance
      • 9.5.5.3. Product & service benchmarking
      • 9.5.5.4. Strategic initiatives
    • 9.5.6. QIAGEN
      • 9.5.6.1. Company overview
      • 9.5.6.2. Financial performance
      • 9.5.6.3. Product & service benchmarking
      • 9.5.6.4. Strategic initiatives
    • 9.5.7. PacBio
      • 9.5.7.1. Company overview
      • 9.5.7.2. Financial performance
      • 9.5.7.3. Product & service benchmarking
      • 9.5.7.4. Strategic initiatives
    • 9.5.8. Oxford Nanopore Technologies plc.
      • 9.5.8.1. Company overview
      • 9.5.8.2. Financial performance
      • 9.5.8.3. Product & service benchmarking
      • 9.5.8.4. Strategic initiatives
    • 9.5.9. Illumina, Inc.
      • 9.5.9.1. Company overview
      • 9.5.9.2. Financial performance
      • 9.5.9.3. Product & service benchmarking
      • 9.5.9.4. Strategic initiatives
    • 9.5.10. 10x Genomics, Inc.
      • 9.5.10.1. Company overview
      • 9.5.10.2. Financial performance
      • 9.5.10.3. Product & service benchmarking
      • 9.5.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global precision genomic testing market, by region, 2018 - 2030 (USD Billion)
  • Table 3 Global precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
  • Table 4 Global precision genomic testing market, by application, 2018 - 2030 (USD Billion)
  • Table 5 Global precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
  • Table 6 Global precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
  • Table 7 North America precision genomic testing market, by country, 2018 - 2030 (USD Billion)
  • Table 8 North America precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
  • Table 9 North America precision genomic testing market, by application, 2018 - 2030 (USD Billion)
  • Table 10 North America precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
  • Table 11 North America precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
  • Table 12 U.S. precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
  • Table 13 U.S. precision genomic testing market, by application, 2018 - 2030 (USD Billion)
  • Table 14 U.S. precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
  • Table 15 U.S. precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
  • Table 16 Canada precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
  • Table 17 Canada precision genomic testing market, by application, 2018 - 2030 (USD Billion)
  • Table 18 Canada precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
  • Table 19 Canada precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
  • Table 20 Mexico precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
  • Table 21 Mexico precision genomic testing market, by application, 2018 - 2030 (USD Billion)
  • Table 22 Mexico precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
  • Table 23 Mexico precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
  • Table 24 Europe precision genomic testing market, by country, 2018 - 2030 (USD Billion)
  • Table 25 Europe precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
  • Table 26 Europe precision genomic testing market, by application, 2018 - 2030 (USD Billion)
  • Table 27 Europe precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
  • Table 28 Europe precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
  • Table 29 UK precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
  • Table 30 UK precision genomic testing market, by application, 2018 - 2030 (USD Billion)
  • Table 31 UK precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
  • Table 32 UK precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
  • Table 33 Germany precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
  • Table 34 Germany precision genomic testing market, by application, 2018 - 2030 (USD Billion)
  • Table 35 Germany precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
  • Table 36 Germany precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
  • Table 37 France precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
  • Table 38 France precision genomic testing market, by application, 2018 - 2030 (USD Billion)
  • Table 39 France precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
  • Table 40 France precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
  • Table 41 Italy precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
  • Table 42 Italy precision genomic testing market, by application, 2018 - 2030 (USD Billion)
  • Table 43 Italy precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
  • Table 44 Italy precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
  • Table 45 Spain precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
  • Table 46 Spain precision genomic testing market, by application, 2018 - 2030 (USD Billion)
  • Table 47 Spain precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
  • Table 48 Spain precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
  • Table 49 Denmark precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
  • Table 50 Denmark precision genomic testing market, by application, 2018 - 2030 (USD Billion)
  • Table 51 Denmark precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
  • Table 52 Denmark precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
  • Table 53 Sweden precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
  • Table 54 Sweden precision genomic testing market, by application, 2018 - 2030 (USD Billion)
  • Table 55 Sweden precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
  • Table 56 Sweden precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
  • Table 57 Norway precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
  • Table 58 Norway precision genomic testing market, by application, 2018 - 2030 (USD Billion)
  • Table 59 Norway precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
  • Table 60 Norway precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
  • Table 61 Asia Pacific precision genomic testing market, by country, 2018 - 2030 (USD Billion)
  • Table 62 Asia Pacific precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
  • Table 63 Asia Pacific precision genomic testing market, by application, 2018 - 2030 (USD Billion)
  • Table 64 Asia Pacific precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
  • Table 65 Asia Pacific precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
  • Table 66 Japan precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
  • Table 67 Japan precision genomic testing market, by application, 2018 - 2030 (USD Billion)
  • Table 68 Japan precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
  • Table 69 Japan precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
  • Table 70 China precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
  • Table 71 China precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
  • Table 72 China precision genomic testing market, by application, 2018 - 2030 (USD Billion)
  • Table 73 China precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
  • Table 74 India precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
  • Table 75 India precision genomic testing market, by application, 2018 - 2030 (USD Billion)
  • Table 76 India precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
  • Table 77 India precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
  • Table 78 Australia precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
  • Table 79 Australia precision genomic testing market, by application, 2018 - 2030 (USD Billion)
  • Table 80 Australia precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
  • Table 81 Australia precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
  • Table 82 South Korea precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
  • Table 83 South Korea precision genomic testing market, by application, 2018 - 2030 (USD Billion)
  • Table 84 South Korea precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
  • Table 85 South Korea precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
  • Table 86 Thailand precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
  • Table 87 Thailand precision genomic testing market, by application, 2018 - 2030 (USD Billion)
  • Table 88 Thailand precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
  • Table 89 Thailand precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
  • Table 90 Latin America precision genomic testing market, by country, 2018 - 2030 (USD Billion)
  • Table 91 Latin America precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
  • Table 92 Latin America precision genomic testing market, by application, 2018 - 2030 (USD Billion)
  • Table 93 Latin America precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
  • Table 94 Latin America precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
  • Table 95 Brazil precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
  • Table 96 Brazil precision genomic testing market, by application, 2018 - 2030 (USD Billion)
  • Table 97 Brazil precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
  • Table 98 Brazil precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
  • Table 99 Argentina precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
  • Table 100 Argentina precision genomic testing market, by application, 2018 - 2030 (USD Billion)
  • Table 101 Argentina precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
  • Table 102 Argentina precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
  • Table 103 MEA precision genomic testing market, by country, 2018 - 2030 (USD Billion)
  • Table 104 MEA precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
  • Table 105 MEA precision genomic testing market, by application, 2018 - 2030 (USD Billion)
  • Table 106 MEA precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
  • Table 107 MEA precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
  • Table 108 South Africa precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
  • Table 109 South Africa precision genomic testing market, by application, 2018 - 2030 (USD Billion)
  • Table 110 South Africa precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
  • Table 111 South Africa precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
  • Table 112 Saudi Arabia precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
  • Table 113 Saudi Arabia precision genomic testing market, by application, 2018 - 2030 (USD Billion)
  • Table 114 Saudi Arabia precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
  • Table 115 Saudi Arabia precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
  • Table 116 UAE precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
  • Table 117 UAE precision genomic testing market, by application, 2018 - 2030 (USD Billion)
  • Table 118 UAE precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
  • Table 119 UAE precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
  • Table 120 Kuwait precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
  • Table 121 Kuwait precision genomic testing market, by application, 2018 - 2030 (USD Billion)
  • Table 122 Kuwait precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
  • Table 123 Kuwait precision genomic testing market, by end use, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Precision genomic testing market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot-1
  • Fig. 14 Segment snapshot-2
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Market trends & outlook
  • Fig. 17 Porter's five force analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Precision genomic testing market: Product & service outlook key takeaways
  • Fig. 20 Precision genomic testing market: Product & service movement analysis
  • Fig. 21 Consumables market estimates and forecasts, 2018 - 2030 (USD billion)
  • Fig. 22 Kits market estimates and forecasts, 2018 - 2030 (USD billion)
  • Fig. 23 Plasmids market estimates and forecasts, 2018 - 2030 (USD billion)
  • Fig. 24 Reagents market estimates and forecasts, 2018 - 2030 (USD billion)
  • Fig. 25 Equipment market estimates and forecasts, 2018 - 2030 (USD billion)
  • Fig. 26 Services market estimates and forecasts, 2018 - 2030 (USD billion)
  • Fig. 27 Precision genomic testing market: Application outlook key takeaways
  • Fig. 28 Precision genomic testing market: Application movement analysis
  • Fig. 29 Oncology market estimates and forecasts, 2018 - 2030 (USD billion)
  • Fig. 30 Cardiovascular diseases market estimates and forecasts, 2018 - 2030 (USD billion)
  • Fig. 31 Neurological disorders market estimates and forecasts, 2018 - 2030 (USD billion)
  • Fig. 32 Reproductive health market estimates and forecasts, 2018 - 2030 (USD billion)
  • Fig. 33 Rare diseases market estimates and forecasts, 2018 - 2030 (USD billion)
  • Fig. 34 Others market estimates and forecasts, 2018 - 2030 (USD billion)
  • Fig. 35 Precision genomic testing market: Technology outlook key takeaways
  • Fig. 36 Precision genomic testing market: Technology movement analysis
  • Fig. 37 Next-generation sequencing market estimates and forecasts, 2018 - 2030 (USD billion)
  • Fig. 38 Polymerase chain reaction market estimates and forecasts, 2018 - 2030 (USD billion)
  • Fig. 39 Microarray technology market estimates and forecasts, 2018 - 2030 (USD billion)
  • Fig. 40 Sanger sequencing market estimates and forecasts, 2018 - 2030 (USD billion)
  • Fig. 41 CRISPR/Cas systems market estimates and forecasts, 2018 - 2030 (USD billion)
  • Fig. 42 Others market estimates and forecasts, 2018 - 2030 (USD billion)
  • Fig. 43 Precision genomic testing market: End Use outlook key takeaways
  • Fig. 44 Precision genomic testing market: End Use movement analysis
  • Fig. 45 Hospitals and clinics market estimates and forecasts, 2018 - 2030 (USD billion)
  • Fig. 46 Diagnostic laboratories market estimates and forecasts, 2018 - 2030 (USD billion)
  • Fig. 47 Research & academic institutes companies market estimates and forecasts, 2018 - 2030 (USD billion)
  • Fig. 48 Others market estimates and forecasts, 2018 - 2030 (USD billion)
  • Fig. 49 Regional marketplace outlook, 2024 & 2030 (USD billion)
  • Fig. 50 Regional marketplace: Key takeaways
  • Fig. 51 North America precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
  • Fig. 52 Key country dynamics
  • Fig. 53 U.S. precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
  • Fig. 54 Key country dynamics
  • Fig. 55 Canada precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
  • Fig. 56 Key country dynamics
  • Fig. 57 Mexico precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
  • Fig. 58 Europe precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
  • Fig. 59 Key country dynamics
  • Fig. 60 UK precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
  • Fig. 61 Key country dynamics
  • Fig. 62 Germany precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
  • Fig. 63 Key country dynamics
  • Fig. 64 France precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
  • Fig. 65 Key country dynamics
  • Fig. 66 Spain precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
  • Fig. 67 Key country dynamics
  • Fig. 68 Italy precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
  • Fig. 69 Key country dynamics
  • Fig. 70 Denmark precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
  • Fig. 71 Key country dynamics
  • Fig. 72 Sweden precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
  • Fig. 73 Key country dynamics
  • Fig. 74 Norway precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
  • Fig. 75 Asia Pacific precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
  • Fig. 76 Key country dynamics
  • Fig. 77 Japan precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
  • Fig. 78 Key country dynamics
  • Fig. 79 China precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
  • Fig. 80 Key country dynamics
  • Fig. 81 India precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
  • Fig. 82 Key country dynamics
  • Fig. 83 Australia precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
  • Fig. 84 Key country dynamics
  • Fig. 85 South Korea precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
  • Fig. 86 Key country dynamics
  • Fig. 87 Thailand precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
  • Fig. 88 Key country dynamics
  • Fig. 89 Market participant categorization
  • Fig. 90 Precision genomic testing market position analysis, 2024
  • Fig. 91 Strategic framework